Cargando…

Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment

The mTOR signaling pathway plays a pivotal and intricate role in the pathogenesis of glioblastoma, driving tumorigenesis and proliferation. Mutations or deletions in the PTEN gene constitutively activate the mTOR pathway by expressing growth factors EGF and PDGF, which activate their respective rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Shilpi, Barik, Debashis, Lawrie, Karl, Mohapatra, Iteeshree, Prasad, Sujata, Naqvi, Afsar R., Singh, Amar, Singh, Gatikrushna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573615/ https://www.ncbi.nlm.nih.gov/pubmed/37834408 http://dx.doi.org/10.3390/ijms241914960

Ejemplares similares

Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
por: Singh, Shilpi, et al.
Publicado: (2023)

HIV-1 hypermethylated guanosine cap licenses specialized translation unaffected by mTOR
por: Singh, Gatikrushna, et al.
Publicado: (2021)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

A New Approach to 3D Modeling of Inhomogeneous Populations of Viral Regulatory RNA
por: Osmer, Patrick S., et al.
Publicado: (2020)

Cellular RNA Helicases Support Early and Late Events in Retroviral Replication
por: Singh, Gatikrushna, et al.
Publicado: (2018)

Harnessing the mTOR Pathway for Tuberculosis Treatment
por: Singh, Pooja, et al.
Publicado: (2018)

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies
por: Iwanami, Akio, et al.
Publicado: (2013)

Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
por: Mecca, Carmen, et al.
Publicado: (2018)

Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
por: Singh, Mohini, et al.
Publicado: (2017)

Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
por: Wang, Jingyue, et al.
Publicado: (2023)

Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues
por: Vasudevan, Dinakaran, et al.
Publicado: (2023)

mTOR signaling in glioblastoma: lessons learned from bench to bedside
por: Akhavan, David, et al.
Publicado: (2010)

mTOR Modulates Intercellular Signals for Enlargement and Infiltration in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2020)

Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma
por: Schreck, Karisa C, et al.
Publicado: (2020)

The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

New Avenues in Management of Trichotillomania
por: Chawla, Omna, et al.
Publicado: (2013)

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022)

Anomalous HIV-1 RNA, How Cap-Methylation Segregates Viral Transcripts by Form and Function
por: Boris-Lawrie, Kathleen, et al.
Publicado: (2022)

Boolean implication analysis unveils candidate universal relationships in microbiome data
por: Vo, Daniella, et al.
Publicado: (2021)

Neuronal Activity, Mitogens, and mTOR: Overcoming the Hurdles for the Treatment of Glioblastoma Multiforme
por: Maiese, Kenneth
Publicado: (2015)

Effect of VEGFR, PDGFR and PI3K/mTOR Targeting in Glioblastoma
por: PURCARU, S.O., et al.
Publicado: (2015)

Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
por: Dumas, Anaelle A, et al.
Publicado: (2020)

Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
por: Benavides-Serrato, Angelica, et al.
Publicado: (2020)

Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme
por: Yao, Weiqi, et al.
Publicado: (2021)

Identification of conserved, primary sequence motifs that direct retrovirus RNA fate
por: Singh, Gatikrushna, et al.
Publicado: (2018)

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues
por: Singh, Rajan, et al.
Publicado: (2021)

Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review)
por: Boda, Daniel, et al.
Publicado: (2018)

Exosomal miRNAs as novel avenues for breast cancer treatment
por: Singh, Tejveer, et al.
Publicado: (2023)

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
por: Exner, Samantha, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
por: Zheng, Xiangjin, et al.
Publicado: (2021)

The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?
por: Naqvi, Raza Ali, et al.
Publicado: (2023)

PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
por: Li, Xiaoman, et al.
Publicado: (2016)

Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway
por: Wang, Jiwei, et al.
Publicado: (2016)

Arctigenin Inhibits Glioblastoma Proliferation through the AKT/mTOR Pathway and Induces Autophagy
por: Jiang, Yong'an, et al.
Publicado: (2020)

The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma
por: Bahmad, Hisham F., et al.
Publicado: (2018)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
por: Wan, Sicheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_drsi397rd1i75pcdprpbukfa3r